Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Gene Editing Research Scientist

Gene Editing Research Scientist nan Vertex Pharmaceuticals Incorporated: Salè H-1B

5 aplikasyon kondisyon travay pou tit travay Gene Editing Research Scientist nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $104,416; mwatye mitan $104,416–$106,811.

Demann (LCA)5
Salè medyan ofri$104,416
Mwatye salè yo$104,416–$106,811
10yèm–90yèm pousantaj$98,101–$107,524

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20243$104,416
FY20251$104,416
FY20261$108,000

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$108,000–$162,000
Nivo II
Boston, MAApr 17, 2026Oct 1, 2026Certifye
$104,416–$140,300
Nivo II
Boston, MASep 24, 2024Oct 1, 2024Certifye
$104,416–$140,300
Nivo II
Boston, MAAug 15, 2024Oct 1, 2024Certifye
$106,811–$144,509
Nivo II
Boston, MAApr 16, 2024Oct 1, 2024Certifye
$93,891–$138,000
Nivo II
Boston, MAApr 16, 2024Oct 1, 2024Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).